Rhoen Klinikum (RHK) Q1 2026 earnings summary

Executive summary

• Revenue rose 5.2% year-over-year to €436.1 million in Q1 2026, driven by higher patient numbers and increased state base rates.

• EBITDA increased 33.6% to €30.2 million, and EBIT nearly doubled to €15.5 million, reflecting operational improvements.

• Consolidated profit grew 79.5% to €13.1 million, supported by invoice mark-ups and higher patient volumes.

• The acquisition of Ortho Centrum Saale MVZ GmbH was completed, strengthening the clinical and outpatient segment.

Financial highlights

• Revenues: €436.1 million (up €21.4 million, +5.2% year-over-year).

• EBITDA: €30.2 million (up €7.6 million, +33.6%).

• EBIT: €15.5 million (up €7.5 million, +93.8%).

• EBT: €16.3 million (up €7.1 million, +77.2%).

• Consolidated profit: €13.1 million (up €5.8 million, +79.5%).

• Earnings per share: €0.19 (up from €0.11 year-over-year).

Outlook and guidance

• Sector faces ongoing restructuring due to recent hospital reforms and legislative changes.

• Uncertainties remain regarding future hospital financing and statutory health insurance reforms.

• Company is well-positioned for transformation initiatives and sector challenges.